Skip to main content
Clinical Trials/NCT01607515
NCT01607515CompletedNot Applicable

Non Invasive Measurement of Cardiac Index by Impedance Cardiography

Medical University of Graz2 sites in 1 country89 target enrollmentStarted: March 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
89
Locations
2
Primary Endpoint
Comparison of CI measured by ICG and Thermodilution

Study Overview

Brief Summary

Pulmonary hypertension (PH) is defined as a pulmonary arterial mean pressure (meanPAP) ≥ 25 mmHg in the right heart catheterization.

There are different forms of PH defined in the classification of Dana Point 2008.

PH is diagnosed with right heart catheterization but there are other non invasive methods which can be used for screening like echocardiography, stress echocardiography and cardio pulmonary exercise testing.

For prognosis of PH patients the limitation of the pulmonary circulation is very important. Therefore the cardiac index (CI) is a good parameter for the right ventricular function. The gold standard for CI measures is the thermodilution, an invasive method performed during right heart catheterization.

Detailed Description

In this study the investigators want to evaluate the impedance cardiography (ICG) as a non invasive method for CI measurement. An alternating current of max 400µA and 45 kHz is conducted through the body. The way of the smallest resistance is the blood in the aorta. The impedance changes with the pulsatile blood flow. Out of the Impedance change there can be calculated the CI.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients who have right heart catheterization written informed consent

Exclusion Criteria

  • patients who don't have right heart catheterization no written informed consent

Arms & Interventions

suspected PH

Other

Patients who undergo right heart catheterization for PH diagnosis undergo impedance cardiography

Intervention: Impedance cardiography (Other)

Outcomes

Primary Outcomes

Comparison of CI measured by ICG and Thermodilution

Time Frame: recruitment over 1.5 year (Data collection), followed by data analysis and interpretation (overall 2 yearsfrom start of recruitment)

assessment of the Specificity and sensitivity of ICG for CI measurement

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Medical University of Graz
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials